ACL — Australian Clinical Labs Share News
0.000.00%
- AU$529.23m
- AU$841.21m
- AU$735.75m
Brief: Australia's ACCC Consults On ACL's Proposed Divestiture For Healius Bid
Regulator asks Australian Clinical to divest collection centres for Healius buyout (updated)
Regulator asks Australian Clinical Labs to divest collection centres
Factbox: Australia Inc roiled by string of cyber attacks since late 2022
Brief: Australian Clinical Labs Provides Update on ACCC Review Timeline On Takeover Offer for Healius
Factbox: Australia Inc roiled by raft of cyber attacks since late 2022
Brief: Australian Clinical Labs Ltd Says Update On Offer For Healius
Brief: Australian Clinical Labs Says Michael Alscher Will Return To His Role As Chair Of Company
Australian Clinical Labs hits all-time low on weak FY results
Brief: Australia's ACCC Says ACL'S Proposed Acquisition Of Healius Raises Concerns
Regulator flags concerns on Australian Clinical's buyout offer for Healius (updated)
Regulator flags concerns on Australian Clinical's buyout offer for Healius
Brief: Australian Clinical Labs Says Chair, Michael Alscher, Is Taking Temporary Leave
Factbox: Australia Inc roiled by raft of cyber attacks since late 2022
Factbox: Australia Inc roiled by raft of cyber attacks since late 2022
Morningstar initiates coverage on Australian Clinical Labs
Brief: Australian Clinical Labs Responds To Healius' Target's Statement
Factbox: Australia Inc roiled by raft of cyber attacks since late 2022
Brief: Australian Clinical Labs Says Reviewing Healius' Target's Statement